Welcome To Taro U.S.A.

Taro markets a broad range of prescription and over-the-counter products in the United States.  We are a leading manufacturer and supplier of topical dermatological products and also have a growing line of solid dosage form products used mainly in cardiology and neurology.

We’re proud that millions of Americans rely on our generic pharmaceuticals and over-the-counter private-label products every year.  Whether you're a physician, pharmacist or patient, please consider this website your personal resource for learning more about Taro.

Press Releases

March 27, 2014
Taro Announces Results of Its Extraordinary General Meeting of Shareholders

February 10, 2014
Taro Provides Results for December 31, 2013

January 23, 2014
Taro Schedules Extraordinary General Meeting for March 27, 2014

December 30, 2013
Taro Announces Final Results of Its Self-Tender Offer

December 24, 2013
Taro Announces Preliminary Results of Its Self-Tender Offer

November 25, 2013
Taro Announces Commencement of Tender Offer to Repurchase up to $200 Million of Its Ordinary Shares

Privacy Statement   |   Terms of Use   |   Safe Harbor Statement   |   Useful Taro Links